Bio-Reference Laboratories, Inc.
When you look at the S&P 500’s most shorted stocks, all are cheap yet short investors continue to bet on lower prices. Therefore, I am looking at the most shorted stocks according to Bespoke Investment Group’s monthly list, to determine if any are a “buy.”
Short-Interest vs. Float
Shares Short (4/30)
Shares Short (3/30)
Blyth (NYSE: BTH)
5.32 more »
Last year I had a problem. I had taken some profit on part of my investment in Apple and needed somewhere to put the gains.
I bought three stocks, and two of them enjoyed significant run-ups. I nearly doubled my investment in one of them within six months. The third has dropped slightly.
Apple had experienced a nice run up over the previous few years (and I had realized a more »
The average American household had an income of $63,385 and spent $49,705 in 2011. Where did all the money go?
The following chart shows the portion of total spending by major category as well as the trend observed since 2000 (not adjusted for inflation). The information was compiled by the U.S. Dept. of Labor.
Portion of Total Spending (2011)
Annualized Increase (*)
Moderately more »
Here is a review of some earnings announcements made over the past few weeks.
Bio-Reference Laboratories (NASDAQ: BRLI): The Elmwood Park, NJ based medical testing laboratory is the fourth largest in the country. It has a broad customer base of physician's offices, clinics, hospitals, private companies and some government entities, and there is plenty of room to expand.
For the quarter ending Oct. 31, Bio-Reference reported a 16% increase more »
Most of my new investments over the past few years have been in dividend paying stocks. As I transition to retirement I will need to supplement my pension and part-time work income.
However, last week I bought three growth stocks to address the other part of my plan to ensure that my portfolio can also reap even higher returns than those typically offered by the stalwart, but relatively slower growth more »
Forbes magazine just published an article about the best small, public companies in the U.S. right now. One of the criteria was for current revenue to be less than $1 billion. Included in the story is commentary from Jack Dorsey, founder of Twitter and Square, about the essential challenges that exist for some of them today. You can read the online article here.
The print version of the story more »
Quest Diagnostics Inc. (NYSE: DGX) and Laboratory Corporation of America (NYSE: LH) are two giants in the diagnostic testing business which is experiencing shifting domestic population demographics, changing laws and regulations, and changing customer preferences. Another player in the industry is the much smaller Bio-Reference Laboratories Inc. (NASDAQ: BRLI) which operates primarily in metro New York. Quest's position as the market leader should result in above market returns for more »
When most people are asked by their doctor where they would like to go to get their blood drawn or a test done the choices are usually Quest Diagnostics (NYSE: DGX) or Labcorp (NYSE: LH). These two titans of the testing and analysis industry have more locations and are generally well known. In beginning to write this I expected to compare these two and see which looked like the better buy. Then something happened, I realized they have a much smaller competitor that is crushing both of their results. Who is this small fry in the same business? - Bio-Reference Laboratories (NASDAQ: BRLI).
If you hold shares in Bio Reference Labs (NASDAQ:BRLI), you might have an ideal set of circumstances to consider some tax loss selling.